The FDA has announced the breakthrough therapy status of the combination of two Roche antibodies
The American regulator has granted the status of an orphan-drug to the experimental drug AZP-3601 manufactured by Amolyt Pharma.
Scientists have introduced a new class of drugs for treating PMS symptoms.
The effect of taking certain antioxidants on the risk of developing Parkinson's disease has been studied.
«Every little thing counts in a crisis» - Jawaharlal Nehru"
Scientists from the University of Montana have developed a thermostable gel for ear drops.
Rani Therapeutics has long been working on a robotic tablet designed to replace drug injections requiring frequent administration.
For the first time scientists have successfully used CRISPR-Cas9 genome editing technology to treat malignant tumors.
Scientists from America have managed to develop a promising compound - T405, which can destroy an extremely dangerous pathogen Mycobacterium abscessus, which is resistant to existing antibiotics.